相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging
Christoph J. Zech et al.
EUROPEAN RADIOLOGY (2020)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
Nina Bastati et al.
RADIOLOGY (2020)
T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis
David H. Hoffman et al.
ABDOMINAL RADIOLOGY (2020)
Systematic review: The diagnostic efficacy of gadoxetic acid-enhanced MRI for liver fibrosis staging
Dawei Yang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2020)
A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion
Daniel Truhn et al.
EUROPEAN RADIOLOGY (2019)
Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI
Dorothea Theilig et al.
EUROPEAN RADIOLOGY (2019)
T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B1 inhomogeneity-corrected variable flip angle method
Ji Eun Kim et al.
EUROPEAN RADIOLOGY (2019)
Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases
Lucian Beer et al.
EUROPEAN RADIOLOGY (2019)
Consistency of hepatocellular gadoxetic acid uptake in serial MRI examinations for evaluation of liver function
Dorothea Theilig et al.
ABDOMINAL RADIOLOGY (2019)
Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging
N. Verloh et al.
PLOS ONE (2019)
A pharmacokinetic model including arrival time for two inputs and compensating for varying applied flip-angle in dynamic gadoxetic acid-enhanced MR imaging
Tian Zhang et al.
PLOS ONE (2019)
Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio
Jeong Hee Yoon et al.
RADIOLOGY (2019)
Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy
Pallavi Pandey et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test
Dong Kyun Kim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI
Lukas Haider et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2018)
Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?
Kumar Sandrasegaran et al.
EUROPEAN RADIOLOGY (2018)
Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test
Michael Haimerl et al.
EUROPEAN RADIOLOGY (2018)
Post-hepatectomy liver failure after major hepatic surgery: not only size matters
Ulrika Asenbaum et al.
EUROPEAN RADIOLOGY (2018)
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
Zobair M. Younossi et al.
HEPATOLOGY (2018)
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Eduardo Vilar-Gomez et al.
JOURNAL OF HEPATOLOGY (2018)
Progression and regression of fibrosis in viral hepatitis in the treatment era: the Beijing classification
Neil D. Theise et al.
MODERN PATHOLOGY (2018)
Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols
Kristina Ringe et al.
PLOS ONE (2018)
Hepatic Gadoxetic Acid Uptake as a Measure of Diffuse Liver Disease: Where Are We?
Ahmed Ba-Ssalamah et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
Respiratory Motion Artifacts During Arterial Phase Imaging With Gadoxetic Acid: Can the Injection Protocol Minimize This Drawback?
Stephan H. Polanec et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
Quantitative Imaging in Diffuse Liver Diseases
Bernard E. Van Beers et al.
SEMINARS IN LIVER DISEASE (2017)
Comparison of 10-and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic
Zhi-Peng Zhou et al.
ABDOMINAL RADIOLOGY (2017)
Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection?
A. F. Costa et al.
CLINICAL RADIOLOGY (2017)
The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis-a multiparametric approach
Diana Feier et al.
EUROPEAN RADIOLOGY (2016)
Graft complications following orthotopic liver transplantation: Role of non-invasive cross-sectional imaging techniques
Piero Boraschi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters
Nina Bastati et al.
INVESTIGATIVE RADIOLOGY (2016)
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
Mattias Mandorfer et al.
JOURNAL OF HEPATOLOGY (2016)
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies
Ying Peng et al.
MEDICINE (2016)
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses
M. Mandorfer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Aijaz Ahmed et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging
Y. Ding et al.
CLINICAL RADIOLOGY (2015)
MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity
Christophe Cassinotto et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
New imaging techniques for liver diseases
Bernard E. Van Beers et al.
JOURNAL OF HEPATOLOGY (2015)
3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function
Cecilia Besa et al.
MAGNETIC RESONANCE IMAGING (2015)
Functional MR imaging of the liver
A. Wibmer et al.
RADIOLOGE (2015)
Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging
Ahmed Ba-Ssalamah et al.
RADIOLOGY (2015)
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
R. Kwok et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Diagnostic workup of primary sclerosing cholangitis: The benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography
R. Nolz et al.
CLINICAL RADIOLOGY (2014)
Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease
Ying Ding et al.
EUROPEAN RADIOLOGY (2014)
Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests
Guido M. Kukuk et al.
EUROPEAN RADIOLOGY (2014)
Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma
Hanke J. Schalkx et al.
EUROPEAN RADIOLOGY (2014)
Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla
N. Verloh et al.
EUROPEAN RADIOLOGY (2014)
Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid-enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study
Nina Bastati et al.
RADIOLOGY (2014)
P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker
Ahmed Ba-Ssalamah et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases
Junichi Shindoh et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
The burden of liver disease in Europe: A review of available epidemiological data
Martin Blachier et al.
JOURNAL OF HEPATOLOGY (2013)
Usefulness of Gd-EOB-DTPA-enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitis
Zhuo Wu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Liver Failure after Major Liver Resection: Risk Assessment by Using Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging
Andreas Wibmer et al.
RADIOLOGY (2013)
Liver Fibrosis: Histopathologic and Biochemical Influences on Diagnostic Efficacy of Hepatobiliary Contrast-enhanced MR Imaging in Staging
Diana Feier et al.
RADIOLOGY (2013)
Comparison of Acute Transient Dyspnea after Intravenous Administration of Gadoxetate Disodium and Gadobenate Dimeglumine: Effect on Arterial Phase Image Quality
Matthew S. Davenport et al.
RADIOLOGY (2013)
Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases
Jelena Djokic Kovac et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis
Tobias Heye et al.
EUROPEAN RADIOLOGY (2012)
The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis
Seung Up Kim et al.
JOURNAL OF HEPATOLOGY (2012)
Primovist, Eovist: What to expect?
Bernard E. Van Beers et al.
JOURNAL OF HEPATOLOGY (2012)
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis
Akihiko Kanki et al.
MAGNETIC RESONANCE IMAGING (2012)
Combined Quantification of Liver Perfusion and Function with Dynamic Gadoxetic Acid-enhanced MR Imaging
Steven Sourbron et al.
RADIOLOGY (2012)
The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: A preliminary study
Seung Hyun Cho et al.
EUROPEAN JOURNAL OF RADIOLOGY (2011)
Gd-EOB-DTPA-enhanced MR imaging: Evaluation of hepatic enhancement effects in normal and cirrhotic livers
Tsutomu Tamada et al.
EUROPEAN JOURNAL OF RADIOLOGY (2011)
Double-Dose Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients With Chronic Liver Disease
Utaroh Motosugi et al.
INVESTIGATIVE RADIOLOGY (2011)
Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging Versus Contrast-Enhanced 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for the Detection of Colorectal Liver Metastases
Hyo Jung Seo et al.
INVESTIGATIVE RADIOLOGY (2011)
Estimation of Liver Function Using T1 Mapping on Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging
Takashi Katsube et al.
INVESTIGATIVE RADIOLOGY (2011)
Staging Hepatic Fibrosis: Comparison of Gadoxetate Disodium-enhanced and Diffusion-weighted MR Imaging-Preliminary Observations
Haruo Watanabe et al.
RADIOLOGY (2011)
Nonalcoholic Fatty Liver Disease: A Review and Update
Jeffrey R. Lewis et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
New proposal for the staging of nonalcoholic steatohepatitis: Evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI
Natsuko Tsuda et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases
Kotaro Shimada et al.
EUROPEAN RADIOLOGY (2010)
Now There Are Many (Stages) Where Before There Was One: In Search of a Pathophysiological Classification of Cirrhosis
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2010)
Hepatocellular Carcinoma: Hepatocyte-selective Enhancement at Gadoxetic Acid-enhanced MR Imaging-Correlation with Expression of Sinusoidal and Canalicular Transporters and Bile Accumulation
Takahiro Tsuboyama et al.
RADIOLOGY (2010)
Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection
T. R. O'Rourke et al.
EJSO (2009)
Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions
Ahmed Ba-Ssalamah et al.
EUROPEAN RADIOLOGY (2009)
Vascular Enhancement in Early Dynamic Liver MR Imaging in an Animal Model: Comparison of Two Injection Regimen and Two Different Doses Gd-EOB-DTPA (Gadoxetic Acid) With Standard Gd-DTPA
Christoph J. Zech et al.
INVESTIGATIVE RADIOLOGY (2009)
Biliary MR Imaging with Gd-EOB-DTPA and Its Clinical Applications
Nam Kyung Lee et al.
RADIOGRAPHICS (2009)
Hepatobiliary-specific MR Contrast Agents: Role in Imaging the Liver and Biliary Tree
Melanie K. Seale et al.
RADIOGRAPHICS (2009)
MR contrast agents for liver imaging: What, when, how
Sunil N. Gandhi et al.
RADIOGRAPHICS (2006)
Model for End-Stage Liver Disease (MELD) and allocation of donor livers
R Wiesner et al.
GASTROENTEROLOGY (2003)
Contrast agents for MR imaging of the liver
RC Semelka et al.
RADIOLOGY (2001)
分享论文
